Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare NYSE:ABX NASDAQ:DMAA NYSE:ESRT NYSE:RPC On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeABXAbacus Global Management$9.42-1.5%$8.95$4.60▼$10.53$903.59M0.11596,641 shs158,795 shsDMAADrugs Made In America Acquisition$10.610.0%$10.54$10.12▼$10.61$257.49M0.01121,322 shs345 shsESRTEmpire State Realty Trust$5.78+3.5%$5.37$4.87▼$8.76$995.78M1.351.58 million shs303,928 shsRPCRidgepost Capital$8.47-0.4%$7.74$6.79▼$13.08$926.75M0.88681,709 shs77,379 shs10 Stocks Set to Soar in 2026Enter your email address and we’ll send you MarketBeat’s list of ten stocks set to soar in Summer 2026, despite the threat of tariffs and what's happening in Iran. These ten stocks are incredibly resilient and are likely to thrive in any economic environment. Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceABXAbacus Global Management+6.50%+8.28%+3.92%+9.97%-26.38%DMAADrugs Made In America Acquisition+0.09%+0.24%+0.57%+1.34%+1,060,999,900.00%ESRTEmpire State Realty Trust+0.27%+2.66%+0.63%-8.29%-23.29%RPCRidgepost Capital+2.84%+3.34%+10.72%+2.65%+851,999,900.00%Compare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeABXAbacus Global Management$9.42-1.5%$8.95$4.60▼$10.53$903.59M0.11596,641 shs158,795 shsDMAADrugs Made In America Acquisition$10.610.0%$10.54$10.12▼$10.61$257.49M0.01121,322 shs345 shsESRTEmpire State Realty Trust$5.78+3.5%$5.37$4.87▼$8.76$995.78M1.351.58 million shs303,928 shsRPCRidgepost Capital$8.47-0.4%$7.74$6.79▼$13.08$926.75M0.88681,709 shs77,379 shs10 Stocks Set to Soar in 2026Enter your email address and we’ll send you MarketBeat’s list of ten stocks set to soar in Summer 2026, despite the threat of tariffs and what's happening in Iran. These ten stocks are incredibly resilient and are likely to thrive in any economic environment. Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceABXAbacus Global Management+6.50%+8.28%+3.92%+9.97%-26.38%DMAADrugs Made In America Acquisition+0.09%+0.24%+0.57%+1.34%+1,060,999,900.00%ESRTEmpire State Realty Trust+0.27%+2.66%+0.63%-8.29%-23.29%RPCRidgepost Capital+2.84%+3.34%+10.72%+2.65%+851,999,900.00%Compare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceABXAbacus Global Management 2.00Hold$10.006.16% UpsideDMAADrugs Made In America Acquisition 1.00SellN/AN/AESRTEmpire State Realty Trust 1.33Sell$6.359.96% UpsideRPCRidgepost Capital 2.50Moderate Buy$12.0041.76% UpsideCurrent Analyst Ratings BreakdownLatest DMAA, ESRT, RPC, and ABX Analyst RatingsDateCompanyBrokerageActionRatingPrice TargetDetails5/11/2026ESRTEmpire State Realty Trust Weiss RatingsSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingDowngradeSell (D+) ➝ Sell (D)5/8/2026RPCRidgepost Capital OppenheimerSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingReiterated RatingOutperform5/8/2026ABXAbacus Global Management Piper SandlerSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingBoost Price TargetNeutral$9.50 ➝ $10.005/8/2026RPCRidgepost Capital BarclaysSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingBoost Price TargetOverweight$11.00 ➝ $12.004/15/2026ESRTEmpire State Realty Trust CitigroupSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingLower Price TargetNeutral$7.00 ➝ $5.754/7/2026ABXAbacus Global Management Piper SandlerSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingLower Price TargetNeutral$11.00 ➝ $9.503/23/2026RPCRidgepost Capital Zacks ResearchSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingDowngradeStrong-Buy ➝ Hold3/13/2026ABXAbacus Global Management Piper SandlerSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingDowngradeOverweight ➝ Neutral$11.003/4/2026ESRTEmpire State Realty Trust Weiss RatingsSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingDowngradeHold (C-) ➝ Sell (D+)3/2/2026ESRTEmpire State Realty Trust Wells Fargo & CompanySubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingLower Price TargetUnderweight$6.80 ➝ $6.303/2/2026RPCRidgepost Capital BarclaysSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingLower Price TargetOverweight$12.00 ➝ $11.00(Data available from 5/27/2023 forward. View 10+ years of historical ratings with our analyst ratings screener.)Compare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookABXAbacus Global Management$250.49M3.61$1.06 per share8.89$4.35 per share2.17DMAADrugs Made In America AcquisitionN/AN/AN/AN/AN/AN/AESRTEmpire State Realty Trust$768.27M1.30$1.55 per share3.72$10.58 per share0.55RPCRidgepost Capital$297.35M3.12$0.93 per share9.08$3.68 per share2.30Compare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateABXAbacus Global Management$36.53M$0.3924.158.26N/A15.63%20.02%9.65%N/ADMAADrugs Made In America AcquisitionN/AN/AN/AN/AN/AN/AN/AN/AN/AESRTEmpire State Realty Trust$47.60M$0.2622.21N/AN/A5.09%2.19%0.93%7/22/2026 (Estimated)RPCRidgepost Capital$19.50M$0.2238.489.01N/A7.99%24.58%10.56%N/ALatest DMAA, ESRT, RPC, and ABX EarningsDateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails5/14/2026Q1 2026DMAADrugs Made In America AcquisitionN/A$0.06N/A$0.06N/AN/A3/12/2026Q4 2025ABXAbacus Global Management$0.20$0.23+$0.03$0.07N/A$71.90 millionCompare DividendsCompanyAnnual PayoutDividend Yield5-Year Annualized Dividend GrowthPayout RatioYears of Consecutive GrowthABXAbacus Global Management$0.282.92%N/A71.79%N/ADMAADrugs Made In America AcquisitionN/AN/AN/AN/AN/AESRTEmpire State Realty Trust$0.142.50%-7.79%53.85%N/ARPCRidgepost Capital$0.151.76%N/A68.18%N/ALatest DMAA, ESRT, RPC, and ABX DividendsAnnouncementCompanyPeriodAmountYieldEx-Dividend DateRecord DatePayable Date5/15/2026ESRTEmpire State Realty Trustquarterly$0.03502.6%6/15/20266/15/20266/30/20265/5/2026RPCRidgepost Capitalquarterly$0.041.9%5/29/20265/29/20266/18/2026(Data available from 1/1/2013 forward)Compare DebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioABXAbacus Global Management0.791.911.91DMAADrugs Made In America AcquisitionN/AN/AN/AESRTEmpire State Realty Trust1.221.941.94RPCRidgepost Capital0.932.702.70Compare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipABXAbacus Global ManagementN/ADMAADrugs Made In America AcquisitionN/AESRTEmpire State Realty Trust67.10%RPCRidgepost Capital48.05%Insider OwnershipCompanyInsider OwnershipABXAbacus Global Management47.00%DMAADrugs Made In America Acquisition0.90%ESRTEmpire State Realty Trust15.20%RPCRidgepost Capital11.54%Compare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableABXAbacus Global Management8295.92 million50.84 millionN/ADMAADrugs Made In America Acquisition224.28 million24.06 millionN/AESRTEmpire State Realty Trust670172.43 million146.22 millionOptionableRPCRidgepost Capital180109.48 million96.84 millionN/ADMAA, ESRT, RPC, and ABX HeadlinesRecent News About These CompaniesStellus Capital Management Closes Stellus Credit Fund IVMay 19, 2026 | prnewswire.comReviewing Bitventures (NASDAQ:BVC) & Ridgepost Capital (NYSE:RPC)May 16, 2026 | americanbankingnews.comRidgepost Capital (NYSE:RPC) Stock Rating Upgraded by Wall Street ZenMay 16, 2026 | americanbankingnews.comRidgepost Capital, Inc 2026 Q1 - Results - Earnings Call PresentationMay 11, 2026 | seekingalpha.comRidgepost Capital, Inc (NYSE:RPC) Increases Dividend to $0.04 Per ShareMay 7, 2026 | marketbeat.comRidgepost Capital, Inc. (RPC) Reports Q1 Earnings: What Key Metrics Have to SayMay 7, 2026 | zacks.comRidgepost Capital, Inc. (RPC) Q1 Earnings Beat EstimatesMay 7, 2026 | zacks.comRidgepost Capital Announces First Quarter 2026 ResultsMay 7, 2026 | globenewswire.comCullen/Frost Bankers (CFR) Q1 Earnings and Revenues Top EstimatesApril 30, 2026 | zacks.comRidgepost Capital, Inc. (RPC) Earnings Expected to Grow: Should You Buy?April 30, 2026 | zacks.comWill Ridgepost Capital, Inc. (RPC) Beat Estimates Again in Its Next Earnings Report?April 28, 2026 | zacks.comHead to Head Comparison: Ridgepost Capital (NYSE:RPC) vs. Virtu Financial (NYSE:VIRT)April 19, 2026 | defenseworld.netDRidgepost Capital Schedules First Quarter 2026 Earnings Release for Thursday, May 7, 2026April 15, 2026 | globenewswire.comBonaccord Capital Partners Announces Minority Investment in Prime FinanceMarch 26, 2026 | globenewswire.comRidgepost Capital, Inc: Ridgepost Capital Announces Retirement of Mark Hood as EVP and CAOMarch 23, 2026 | finanznachrichten.deRidgepost Capital Announces Retirement of Mark Hood as EVP and CAOMarch 23, 2026 | globenewswire.comAre options traders betting on a big move in Ridgepost Capital stock?March 17, 2026 | msn.comEnhanced Capital Named to the ImpactAssets 50 2026, the Definitive Guide to Impact Investing Fund ManagersMarch 17, 2026 | globenewswire.comInsider Buying: Ridgepost Capital (NYSE:RPC) Insider Acquires 12,500 Shares of StockMarch 17, 2026 | insidertrades.comPayoneer, Sezzle, PROG, Atlanticus Holdings, and Ridgepost Capital Shares Are Falling, What You Need To KnowMarch 12, 2026 | finance.yahoo.comContrasting Uranium Royalty (OTCMKTS:URCCF) and Ridgepost Capital (NYSE:RPC)March 6, 2026 | defenseworld.netDNew MarketBeat Followers Over TimeMedia Sentiment Over TimeDMAA, ESRT, RPC, and ABX Company DescriptionsAbacus Global Management NYSE:ABX$9.42 -0.14 (-1.46%) As of 12:57 PM Eastern This is a fair market value price provided by Massive. Learn more.Abacus Life, Inc. operates as an alternative asset manager specializing in life insurance products. It purchases life insurance policies from consumers seeking liquidity and manages policies over time via trading, holding, and/or servicing. The company was founded in 2004 and is based in Orlando, Florida.Drugs Made In America Acquisition NASDAQ:DMAA$10.60 -0.01 (-0.05%) As of 12:53 PM Eastern This is a fair market value price provided by Massive. Learn more.Drugs Made In America Acquisition Corp. is a blank check company newly incorporated in the Cayman Islands as an exempted company incorporated for the purpose of effecting a merger, share exchange, asset acquisition, share purchase, recapitalization, reorganization, or other similar business combination with one or more businesses. To date, our efforts have been limited to organizational activities as well as activities related to this offering. We have not selected any specific business combination target and we have not, nor has anyone on our behalf, engaged in any substantive discussions, directly or indirectly, with any business combination target with respect to an initial business combination with us. While we may pursue a business combination target in any business, industry or geographical location, we intend to focus our search for businesses in the pharmaceutical industry. Our executive offices are located at 1 East Broward Boulevard, Suite 700, Fort Lauderdale, FL 33301 and our telephone number is (954) 870-3099.Empire State Realty Trust NYSE:ESRT$5.78 +0.20 (+3.49%) As of 12:57 PM Eastern This is a fair market value price provided by Massive. Learn more.Empire State Realty Trust, Inc. (NYSE: ESRT) is a NYC-focused REIT that owns and operates a portfolio of modernized, amenitized, and well-located office, retail, and multifamily assets. The company is the recognized leader in energy efficiency and indoor environmental quality. ESRT's flagship Empire State Building - the "World's Most Famous Building" - includes its Observatory, Tripadvisor's 2023 Travelers' Choice Awards: Best of the Best the #1 attraction in the US for two consecutive years. As of September 30, 2023, ESRT's portfolio is comprised of approximately 8.6 million rentable square feet of office space, 0.7 million rentable square feet of retail space and 727 residential units across three multifamily properties.Ridgepost Capital NYSE:RPC$8.46 -0.04 (-0.53%) As of 12:57 PM Eastern This is a fair market value price provided by Massive. Learn more.P10, Inc., together with its subsidiaries, operates as a multi-asset class private market solutions provider in the alternative asset management industry in the United States. The company offers private equity, venture capital, private credit, impact investing, and private credit services, as well as primary fund of funds, secondary investment, and direct and co-investments services. It also provides tax credit transaction and consulting services. The company was founded in 1992 and is headquartered in Dallas, Texas. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30DroneEcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerFlying CarGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMade In AmericaMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSilverSocial MediaSolarSpaceTechnologyTelecomToyUraniumUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas Rocket Lab Keeps Making Headlines and Highs—Here's What's Driving the Latest Move Micron’s $1 Trillion Memory Melt-Up Modine’s $4B AI Coup Freezes Out the Competition What Investors Need to Know About TSMC's Hefty 17% Dividend Increase AutoZone's Pullback Sets Up a Long-Term Buying Opportunity AST SpaceMobile’s June Launch Plan Puts Its 2026 Satellite Goal Back in Focus Powerhouse Williams-Sonoma Heading to Fresh Highs in 2026 Quantum Stocks Just Got a Lifeline—Who Benefits Most? Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
